Myeloproliferative Neoplasms: Molecular Oncology Tumor Boards

This free case-based activity includes a crowd-sourced discussion of a 61-year-old male who presented with significant thrombocytosis on evaluation of a transient ischemic attack. Presenting with right sided sensory and motor deficits. History is positive for 6 months of fatigue, frequent migraines with complex auras, occasional aquagenic pruritus.

Originally posted on a forum in the ASCO Connection, participants now have the opportunity to claim CME, completion, or participation certificates for completing this activity.

Learning Objectives

  • Analyze how currently identified MPN mutations (both driver and additional somatic mutations) impact an accurate diagnosis of MPNs in alignment with 2016 WHO guidelines
  • Evaluate how currently identified MPN mutations (both their presence and/or allele burden) impact on prognosis in each of the MPNs
  • Identify clinical scenarios where current molecular mutation status may impact MPN clinical decision planning in either observation, medical therapy, or stem cell transplantation

Continuing Education Credit

1 Credit/Point is available for participation in this course. Certificate and credit types available include:

  • AMA PRA Category 1 Credits™ 
  • ABIM MOC Points
  • Certificate of Participation may be used to confer credit; however, all final decisions regarding the awarding of credits will be made by the licensing organization to which the credits are submitted.
  • Certificate of Completion may be used to document participation, but no credit will be conferred.
Important Notes
  • This course expires on July 27, 2019. Participants must complete all necessary course components by this date to receive credit.